Andrew C. Rorie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrew C. Rorie has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Jill A. Poole
Division of Allergy and Immunology, Department of Medicine College of Medicine
4 shared publicationsHarlan R. Sayles
Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska USA
2 shared publicationsAlexander J. Penrice
Division of Allergy and Immunology, Department of Medicine College of Medicine, University of Nebraska Medical Center, Omaha, Neb
1 shared publication- Alexander J. Penrice
Department of Medicine, Division of Allergy and Immunology, University of Nebraska Medical Center, Omaha, NE
1 shared publication - Allison J. Burbank
Department of Pediatrics, Division of Allergy and Immunology, University of North Carolina, Chapel Hill, NC 27599, USA
1 shared publication Amal M. Musa
Department of Internal Medicine
1 shared publication
Latest Publications
- Open Access
- 27 June 2026
- Published by MDPI AG in Atmosphere
- Vol. 17 (7) , 635
Pollen Season Timing and Concentrations in the United States: Developing a Standardized Pollen Dataset Using Data from the National Allergy Bureau (NAB) (2003–2024)
Pollen exposure drives allergic disease in millions of Americans, yet no standardized, publicly available national pollen dataset has existed until now. We describe the first nationally standardized and publicly available dataset of pollen season timing and airborne pollen concentrations. The data were derived from the National Allergy Bureau™ (NAB™), the only pollen and mold measuring network in the United States certified by the American Academy of Allergy, Asthma & Immunology (AAAAI), and curated, processed, and disseminated by the U.S. Centers for Disease Control and Prevention (CDC). The 2003–2024 dataset provides standardized measures of (1) taxa-specific historical average main pollen season (MPS) concentrations and timing (e.g., start dates, peak dates, end dates, season length); (2) taxa-specific yearly MPS concentrations and timing; (3) grouped weekly MPS concentrations, levels, and timing; and (4) grouped daily pollen levels and MPS timing. Pollen concentrations are reported as pollen grains per cubic meter (PPCM). MPS timing is computed using a 3-day consecutive method: season start occurs after the first occurrence of three consecutive days with concentrations > 1.0 PPCM; season peak is the day of maximum concentration; and season end occurs after the first occurrence of three consecutive days with concentrations < 1.0 PPCM after the peak. Historical average timing is calculated in a 365-day-of-year format and converted to calendar dates using 2024 as a reference year for display and consistency. By combining long-term data from monitoring sites across the country, this dataset shows how pollen levels vary over time and across geographic locations. This resource supports tracking pollen trends, linking pollen with weather and climate factors, and informing public health action, clinical care, and communication about population exposure and the impact to allergic diseases such as asthma and hay fever.
- 27 June 2026
- Published by MDPI AG in Atmosphere
- Vol. 17 (7) , 635
Open AccessPollen Season Timing and Concentrations in the United States: Developing a Standardized Pollen Dataset Using Data from the National Allergy Bureau (NAB) (2003–2024)
Pollen exposure drives allergic disease in millions of Americans, yet no standardized, publicly available national pollen dataset has existed until now. We describe the first nationally standardized and publicly available dataset of pollen season timing and airborne pollen concentrations. The data were derived from the National Allergy Bureau™ (NAB™), the only pollen and mold measuring network in the United States certified by the American Academy of Allergy, Asthma & Immunology (AAAAI), and curated, processed, and disseminated by the U.S. Centers for Disease Control and Prevention (CDC). The 2003–2024 dataset provides standardized measures of (1) taxa-specific historical average main pollen season (MPS) concentrations and timing (e.g., start dates, peak dates, end dates, season length); (2) taxa-specific yearly MPS concentrations and timing; (3) grouped weekly MPS concentrations, levels, and timing; and (4) grouped daily pollen levels and MPS timing. Pollen concentrations are reported as pollen grains per cubic meter (PPCM). MPS timing is computed using a 3-day consecutive method: season start occurs after the first occurrence of three consecutive days with concentrations > 1.0 PPCM; season peak is the day of maximum concentration; and season end occurs after the first occurrence of three consecutive days with concentrations < 1.0 PPCM after the peak. Historical average timing is calculated in a 365-day-of-year format and converted to calendar dates using 2024 as a reference year for display and consistency. By combining long-term data from monitoring sites across the country, this dataset shows how pollen levels vary over time and across geographic locations. This resource supports tracking pollen trends, linking pollen with weather and climate factors, and informing public health action, clinical care, and communication about population exposure and the impact to allergic diseases such as asthma and hay fever.
- 27 February 2026
- Published by Springer Nature in Current Allergy and Asthma Reports
- Vol. 26 (1) , 16
The Impact of Extreme Weather Events on Allergic Airway Disease
- 27 February 2026
- Published by Springer Nature in Current Allergy and Asthma Reports
- Vol. 26 (1) , 16
The Impact of Extreme Weather Events on Allergic Airway Disease
- 15 October 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 14 (1) , 185-195
Joint Association of Methamphetamine and Cannabis Use as Risk Factors for Asthma Exacerbations Requiring Hospitalization: A Retrospective Analysis
- 15 October 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 14 (1) , 185-195
Joint Association of Methamphetamine and Cannabis Use as Risk Factors for Asthma Exacerbations Requiring Hospitalization: A Retrospective Analysis
- 15 July 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (10) , 2865-2866.e1
Prospective comparison of dog sensitization rates between skin prick testing extracts: Dog epithelium, acetone precipitated dog, and ultrafiltered dog
- 15 July 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (10) , 2865-2866.e1
Prospective comparison of dog sensitization rates between skin prick testing extracts: Dog epithelium, acetone precipitated dog, and ultrafiltered dog
- 10 March 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (6) , 1281-1288
Climate Change and Allergens: Current and Future Impacts
- 10 March 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (6) , 1281-1288
Climate Change and Allergens: Current and Future Impacts
- Open Access
Incidence and Characteristics of Pediatric Eosinophilic Esophagitis: A Midwestern State Analysis
Background: Eosinophilic esophagitis (EoE) is a chronic disease defined by esophageal dysfunction and >15 eosinophils per high-power-field on biopsy. Despite its increased incidence across the United States, studies evaluating its incidence at any state level are lacking. Methods: Record review of pediatric patients (<18 years) newly diagnosed with EoE based on ICD coding seen at the main two pediatric gastroenterology centers in the state: Children’s Nebraska (1 January 2016–31 December 2022) and Boys Town National Research Hospital (1 January 2022–31 December 2022). Data included demographics, age, and zip codes. Descriptive analysis focused on Nebraska residents. Results: The average point incidence of EoE between 2016 and 2022 was 10.84/100,000 inhabitants based on data from Children’s Nebraska. Considering both centers, the point incidence in Nebraska for 2022 was 32.45/100,000 inhabitants. Caucasians were 3.7 times more likely to be affected and older at time of diagnosis (average 9.7 years) compared to African Americans (7.0), Hispanics (7.4), and Asians (4.4). Conclusions: This is the first study evaluating the incidence of EoE in a specific U.S.A state. Studies at the state level are important to direct policy and interventions aiming limit its burden in communities.
Open AccessIncidence and Characteristics of Pediatric Eosinophilic Esophagitis: A Midwestern State Analysis
Background: Eosinophilic esophagitis (EoE) is a chronic disease defined by esophageal dysfunction and >15 eosinophils per high-power-field on biopsy. Despite its increased incidence across the United States, studies evaluating its incidence at any state level are lacking. Methods: Record review of pediatric patients (<18 years) newly diagnosed with EoE based on ICD coding seen at the main two pediatric gastroenterology centers in the state: Children’s Nebraska (1 January 2016–31 December 2022) and Boys Town National Research Hospital (1 January 2022–31 December 2022). Data included demographics, age, and zip codes. Descriptive analysis focused on Nebraska residents. Results: The average point incidence of EoE between 2016 and 2022 was 10.84/100,000 inhabitants based on data from Children’s Nebraska. Considering both centers, the point incidence in Nebraska for 2022 was 32.45/100,000 inhabitants. Caucasians were 3.7 times more likely to be affected and older at time of diagnosis (average 9.7 years) compared to African Americans (7.0), Hispanics (7.4), and Asians (4.4). Conclusions: This is the first study evaluating the incidence of EoE in a specific U.S.A state. Studies at the state level are important to direct policy and interventions aiming limit its burden in communities.
- 20 December 2024
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (2) , 266-273
The Effect of Climate Change on Allergen and Irritant Exposure
- 20 December 2024
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (2) , 266-273
The Effect of Climate Change on Allergen and Irritant Exposure
- 21 August 2023
- Published by Elsevier in Immunology and Allergy Clinics of North America
- Vol. 44 (1) , 35-44
Extreme Weather Events and Asthma
- 21 August 2023
- Published by Elsevier in Immunology and Allergy Clinics of North America
- Vol. 44 (1) , 35-44
Extreme Weather Events and Asthma
- 24 September 2022
- Published by Elsevier in Immunology and Allergy Clinics of North America
- Vol. 42 (4) , 771-786
Climate Change Factors and the Aerobiology Effect
- 24 September 2022
- Published by Elsevier in Immunology and Allergy Clinics of North America
- Vol. 42 (4) , 771-786
Climate Change Factors and the Aerobiology Effect
- 2 January 2022
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 30 (1) , 54-56
Recalcitrant Herpes Zoster Ophthalmicus in a Patient Discovered to Have Underlying Functional Natural Killer Cell Deficiency
Purpose: To report the management of a patient with chronic herpes zoster ophthalmicus with previously undiagnosed natural killer cell deficiency. Methods: A 50-year-old female presented with herpes zoster ophthalmicus that despite appropriate treatment progressed to uveitis and expansion of the lesions. Multiple attempts to wean the patient off therapeutic anti-viral medications continued to result in reoccurrence of the disease. Discovery of underlying natural killer cell deficiency prompted indefinite treatment with therapeutic anti-viral medication. Results: After multiple flares of herpes zoster ophthalmicus over 3 years, seven prior to the discovery of the immunodeficiency, she developed unilateral corneal scarring on the affected side. At this time, her visual acuity was measured to be uncorrected at 20/150 with improvement to 20/25-1 with refraction. Conclusions: This case highlights the need for further immunological investigation and unconventional medical management with recurrent viral infections to prevent visual morbidity.
- 2 January 2022
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 30 (1) , 54-56
Recalcitrant Herpes Zoster Ophthalmicus in a Patient Discovered to Have Underlying Functional Natural Killer Cell Deficiency
Purpose: To report the management of a patient with chronic herpes zoster ophthalmicus with previously undiagnosed natural killer cell deficiency. Methods: A 50-year-old female presented with herpes zoster ophthalmicus that despite appropriate treatment progressed to uveitis and expansion of the lesions. Multiple attempts to wean the patient off therapeutic anti-viral medications continued to result in reoccurrence of the disease. Discovery of underlying natural killer cell deficiency prompted indefinite treatment with therapeutic anti-viral medication. Results: After multiple flares of herpes zoster ophthalmicus over 3 years, seven prior to the discovery of the immunodeficiency, she developed unilateral corneal scarring on the affected side. At this time, her visual acuity was measured to be uncorrected at 20/150 with improvement to 20/25-1 with refraction. Conclusions: This case highlights the need for further immunological investigation and unconventional medical management with recurrent viral infections to prevent visual morbidity.